Quality of Life and Healthcare Resource Use Associated With Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage
- 1 April 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 43 (4) , 1082-1088
Abstract
Background and Purpose—: In this analysis of data from a large clinical trial in aneurysmal subarachnoid hemorrhage, the impact of angiographic vasospasm (aVSP) on specific patient outcomes and inpatient healthcare resource use was assessed. Methods—: This was a post hoc analysis of exploratory end points collected for 409 patients with aneurysmal subarachnoid hemorrhage in the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) trial. Central reviewers graded severity of aVSP as none, mild, moderate, or severe based on comparison of catheter angiograms obtained at baseline and 7 to 11 days after aneurysmal subarachnoid hemorrhage. Assessments of cognitive status (Mini-Mental State Examination) and patient-relevant outcomes (EuroQol total score and visual analog scale and Functional Status Examination) were administered at Week 12. The relationship between severity of aVSP and these end points as well as inpatient healthcare resource use (intensive care, general ward, and total hospital lengths of stay) was assessed using univariate and multivariate analyses. Results—: Cognitive status and all patient-relevant outcome measures varied significantly ( P P =0.008) and days in the intensive care unit ( P <0.0001). On average, patients with severe aVSP stayed in the hospital 5 days longer than those with no aVSP. Conclusions—: Severe aVSP is associated with poor cognition, worse patient-relevant outcomes, and greater inpatient healthcare resource use. Future studies assessing new aVSP treatments should include outcome measures that evaluate quality of recovery among survivors.Keywords
This publication has 31 references indexed in Scilit:
- Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational StudiesStroke, 2010
- Neuroprotection in Subarachnoid HemorrhageStroke, 2010
- Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United KingdomCost Effectiveness and Resource Allocation, 2010
- PREDICTORS OF GLOBAL COGNITIVE IMPAIRMENT 1 YEAR AFTER SUBARACHNOID HEMORRHAGENeurosurgery, 2009
- Defining Vasospasm After Subarachnoid HemorrhageStroke, 2009
- Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhageBrain, 2009
- Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)Stroke, 2008
- Utility of Outcome Measures After Treatment for Intracranial AneurysmsStroke, 2005
- Functional Status Examination: A New Instrument for Assessing Outcome in Traumatic Brain InjuryJournal of Neurotrauma, 2001
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990